See more : Rush Enterprises, Inc. (RUSHA) Income Statement Analysis – Financial Results
Complete financial analysis of 2cureX AB (publ) (2CUREX.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 2cureX AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Stellar Bancorp, Inc. (STEL) Income Statement Analysis – Financial Results
- NB Private Equity Partners Limited (NBPVF) Income Statement Analysis – Financial Results
- City Service SE (CTS.WA) Income Statement Analysis – Financial Results
- NMDC Steel Limited (NSLNISP.BO) Income Statement Analysis – Financial Results
- Capitan Mining Inc. (CAPT.V) Income Statement Analysis – Financial Results
2cureX AB (publ) (2CUREX.ST)
About 2cureX AB (publ)
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 155.00K | 90.00K | 7.39M | 15.39M | 11.98M | 7.68M | 47.00K | 1.35M | 2.23M |
| Cost of Revenue | 37.64M | 35.50M | 353.00K | 386.00K | 436.00K | 431.00K | 7.88M | 235.99K | 208.17K |
| Gross Profit | -37.49M | -35.41M | 7.04M | 15.01M | 11.55M | 7.24M | -7.83M | 1.11M | 2.03M |
| Gross Profit Ratio | -24,185.16% | -39,346.67% | 95.22% | 97.49% | 96.36% | 94.38% | -16,657.45% | 82.48% | 90.68% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.63M | 0.00 | 0.00 |
| General & Administrative | 0.00 | 12.38M | 11.86M | 10.06M | 9.38M | 6.84M | 3.51M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 36.52M | 12.38M | 11.86M | 10.06M | 9.38M | 6.84M | 3.51M | 2.63M | 3.00M |
| Other Expenses | 0.00 | 19.84M | 10.94M | -2.65M | -627.00K | 1.60M | 510.00K | 2.90M | 3.15M |
| Operating Expenses | 36.52M | 32.22M | 22.80M | 7.42M | 8.75M | 8.44M | 4.02M | 2.90M | 3.15M |
| Cost & Expenses | 36.52M | 32.22M | 22.80M | 7.42M | 8.75M | 8.44M | 4.02M | 2.90M | 3.15M |
| Interest Income | 0.00 | 0.00 | 322.00K | 240.00K | 142.00K | 0.00 | 30.00K | 0.00 | 0.00 |
| Interest Expense | 1.62M | 0.00 | 104.00K | 240.00K | 662.00K | 106.00K | 52.00K | 0.00 | 0.00 |
| Depreciation & Amortization | 312.00K | 311.00K | 353.00K | 386.00K | 436.00K | 431.00K | 290.00K | 235.99K | 204.52K |
| EBITDA | -35.14M | -29.46M | -22.45M | -7.03M | -8.31M | -8.01M | -3.65M | -1.32M | -731.51K |
| EBITDA Ratio | -22,668.39% | -32,732.22% | -297.96% | -51.75% | -69.38% | -104.30% | -7,772.34% | -97.76% | -31.79% |
| Operating Income | -36.36M | -32.13M | -22.80M | -7.42M | -8.75M | -8.44M | -3.97M | -1.56M | -915.03K |
| Operating Income Ratio | -23,460.00% | -35,703.33% | -308.50% | -48.20% | -73.02% | -109.92% | -8,453.19% | -115.50% | -40.95% |
| Total Other Income/Expenses | -784.00K | 2.36M | 322.00K | -1.17M | -662.00K | -106.00K | -22.00K | -24.79K | -8.28K |
| Income Before Tax | -37.15M | -29.77M | -22.48M | -8.59M | -9.41M | -8.54M | -4.00M | -1.56M | -923.31K |
| Income Before Tax Ratio | -23,965.81% | -33,077.78% | -304.14% | -55.82% | -78.54% | -111.30% | -8,500.00% | -115.86% | -41.32% |
| Income Tax Expense | -4.63M | -2.36M | -3.54M | -1.27M | -1.48M | -1.28M | -859.00K | -911.62K | -444.20K |
| Net Income | -32.52M | -27.41M | -18.94M | -7.32M | -7.93M | -7.26M | -3.14M | -649.01K | -479.11K |
| Net Income Ratio | -20,979.35% | -30,452.22% | -256.22% | -47.56% | -66.21% | -94.64% | -6,672.34% | -48.18% | -21.44% |
| EPS | -1.85 | -1.56 | -1.15 | -0.54 | -0.68 | -0.70 | -0.35 | -0.08 | -0.06 |
| EPS Diluted | -1.85 | -1.56 | -1.15 | -0.54 | -0.68 | -0.70 | -0.35 | -0.06 | -0.04 |
| Weighted Avg Shares Out | 17.60M | 17.58M | 16.42M | 13.60M | 11.61M | 10.35M | 8.92M | 8.47M | 8.47M |
| Weighted Avg Shares Out (Dil) | 17.60M | 17.58M | 16.42M | 13.60M | 11.61M | 10.35M | 8.92M | 10.95M | 10.95M |
Source: https://incomestatements.info
Category: Stock Reports